Skip to content

Impact of the Type of Stabilization in the Two-stage Knee Reimplantation on Reinfection - Prospective, Randomized Study.

Impact of the Type of Stabilization in the Two-stage Knee Reimplantation on Reinfection - Prospective, Randomized Study.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04446676
Enrollment
200
Registered
2020-06-25
Start date
2020-11-17
Completion date
2027-01-31
Last updated
2022-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Infection

Keywords

knee arthroplasty, infection, two-stage, sleeve, stem

Brief summary

Participants after first-stage of knee infection reimplantation will be assign to one of two groups: with stem vs. with sleeve. Investigators will check participants on clinical, laboratory and reinfection signs. The main hypothesis is that better mechanical stability of endoprosthesis with sleeves will support infection treatment.

Detailed description

All participants will be treated because of periprosthetic joint infection of the knee, after primary arthroplasty. All participants will be treated with two-stage protocol. In first stage debridement and spacer implantation will be performed. After 6-week antibiotics, when will be absent clinical or laboratory signs of reinfection, second stage will be performed. All participants upon fulfillment all inclusion and exclusion criteria will sign informed consent. With computer software patients will be randomized to one of two groups: with stem vs. with sleeve. After operation all patients will get target antibiotics for 3 weeks. Pre-operation and after on periodic controls will checked the Knee Society Score, The Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC), Visual Analogue Scale. After 2-year observation evaluation of reinfection rate will be performed in both groups.

Interventions

DEVICEstabilization with stem

In both groups revision endoprosthesis of knee will be implanted with stem or sleeve stabilization.

DEVICEstabilization with sleeve

In both groups revision endoprosthesis of knee will be implanted with stem or sleeve stabilization.

Sponsors

Prof A Gruca Teaching Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Intervention model description

Two groups with endoprosthesis stabilisation with stem or sleeve.

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* second-stage of knee reimplantation * primary knee replacement in primary knee osteoarthritis * fulfillment of International Consensus Meeting 2018 infection criteria

Exclusion criteria

* intraoperative bone defects Anderson Orthopedic Research Institute score \>II * autoimmune disease * diabetes * peripheral vascular disease * congenital or acquired immunodeficiencies * lack of pathogens after first-stage * multi-bacterial infection * multidirectional instability * lack of patient consent

Design outcomes

Primary

MeasureTime frameDescription
Reinfection2 yearsRate of reinfection in both groups

Secondary

MeasureTime frameDescription
Loosening radiological signs2 yearsRadiological evaluation of implant loosening with Modern Knee Society Radiographic Evaluation System

Other

MeasureTime frameDescription
Visual Analogue Score1 yearClinical evaluation of patients after knee revision
Alignment6 weeksRadiological alignment of knee after operation in degrees
Knee Society Score1 yearClinical evaluation of patients after knee revision
Erythrocyte sedimentation rate1 yearAfter operation and at period controls (mm/h)
C-reactive protein1 yearAfter operation and at period controls (mg/l)
The Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC)1 yearClinical evaluation of patients after knee revision

Countries

Poland

Contacts

Primary ContactPaweł Bartosz
pbartosz@vp.pl+48 793629685

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026